Menus Subscribe Search

Follow us


Breast Cancer Court Case Pits Patients’ Genes vs. Gene Patents

• April 07, 2011 • 11:23 AM

A court case surrounding gene patents for high-risk forms of breast cancer puts two viewpoints of “products of nature” on the stand.

The United States Court of Appeals for the Federal Circuit heard a case earlier this week involving a fine point of patent law with major implications for public health and science: Can individual human genes be patented by private companies?

The United States Patent and Trademark Office has, in fact, been saying yes for years. According to one 2005 study published by the journal Science, gene patents for 20 percent of the human genome — or more than 4,000 genes — have been created, despite court precedent that says no one can own the “products of nature.”

This particular case, brought by the American Civil Liberties Union and the Public Patent Foundation on behalf of several cancer patients and scientific organizations, revolves around a pair of genes associated with an elevated risk of breast and cervical cancer. The genes BRCA1 and BRCA2 have been patented by the private firm Myriad Genetics, making it the only company that can test and diagnose women for the mutation (at a cost of a few thousand dollars).

“Everybody that we’ve talked to — and we’ve all talked to doctors and told them about this case — everybody’s shocked to know that this DNA is patented,” said Sabrina Hassan, senior counsel for Public Patent.

Last March, a federal court in New York agreed that genes shouldn’t be patented. And then in the fall, the federal government surprisingly filed a friend-of-the-court brief agreeing with the cancer patients and the district judge in Myriad’s appeal. Neal Katyal, the U.S. acting solicitor general, argued in court alongside the ACLU’s lawyers on Monday, effectively opposing the government’s own longstanding policy on the question.

[class name=”dont_print_this”]

Idea Lobby

THE IDEA LOBBY
Miller-McCune's Washington correspondent Emily Badger follows the ideas informing, explaining and influencing government, from the local think tank circuit to academic research that shapes D.C. policy from afar.

[/class] That move looks like a “change of heart” on the government’s part, said Aaron Kesselheim, an assistant professor of medicine at Harvard Medical School. He and colleague Michelle Mello wrote about the case in the New England Journal of Medicine last May, tracking a historical context in U.S. gene patent policy that now appears to be shifting.

“It is significant,” Kesselheim said, “that the government has come out on the plaintiffs’ side on this case and said this probably is not what the Patent Act was meant to cover.”

While the human genome is obviously a product of nature, the patent office has long approved applications by companies for the work of isolating individual genes. Myriad holds patents both on the isolated BRCA1 and BRCA2 and on the process it uses to compare those genes when diagnosing women for the risk.

The lawsuit rests largely on the question of whether merely isolating something in nature should make it patentable — and the court’s ultimate answer would affect not just these two genes but the notion that any DNA is patentable.

“If a surgeon cuts me open and slices out my kidney and takes it out and holds it in his hand, it’s an ‘isolated’ kidney, but it’s still a kidney,” argued ACLU lawyer Chris Hansen in court on Monday. “It’s not an invention.”

The ACLU has also argued that patenting the process of comparing DNA, as Myriad does in its diagnostic tests, is akin to patenting thought.

Myriad counters that gene patents are essential to luring the investment money needed to conduct the research that isolates such DNA in the first place, allowing for the development of advances in personal medicine that benefit society as a whole.

Both parties are, in a sense, arguing that their positions benefit patients. And this touches on the other big question raised by the case: Does society stand to gain more when patents encourage financial investment in scientific innovation or when public ownership of genes spurs wider research and cheaper diagnostic tools?

Kesselheim pointed to one recent study that has tried to answer this question. Economist Heidi Williams compared gene sequencing by the public Human Genome Project with the private firm Celera to determine whether intellectual property rights really spurred innovation. She found that assigning intellectual property to genes sequenced by Celera led to less future research and product development than did the public effort.

If the appeals court upholds the earlier decision in the BRCA case — a substantial break in policy for gene patenting, Kesselheim said, but a narrow one that would not extend to other naturally occurring substances like proteins — Kesselheim predicts society won’t lose out on important basic research. After all, much of the work in this area (including research that led to the genes Myriad ultimately patented) is supported by the government.

But this is a separate policy issue.

“The government is funding this initial research, and on the other hand, patients are paying extremely high costs for the output of the research,” Kesselheim said. “That means patients are paying twice — once in their taxes and once out of their pocket — for the same output.”

Sign up for the free Miller-McCune.com e-newsletter.

“Like” Miller-McCune on Facebook.

Follow Miller-McCune on Twitter.

Add Miller-McCune.com news to your site.

Subscribe to Miller-McCune

Emily Badger
Emily Badger is a freelance writer living in the Washington, D.C. area who has contributed to The New York Times, International Herald Tribune and The Christian Science Monitor. She previously covered college sports for the Orlando Sentinel and lived and reported in France.

More From Emily Badger

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

December 19 • 4:00 PM

How a Drug Policy Reform Organization Thinks of the Children

This valuable, newly updated resource for parents is based in the real world.


December 19 • 2:00 PM

Where Did the Ouija Board Come From?

It wasn’t just a toy.


December 19 • 12:00 PM

Social Scientists Can Do More to Eradicate Racial Oppression

Using our knowledge of social systems, all social scientists—black or white, race scholar or not—have an opportunity to challenge white privilege.


December 19 • 10:17 AM

How Scientists Contribute to Bad Science Reporting

By not taking university press officers and research press releases seriously, scientists are often complicit in the media falsehoods they so often deride.


December 19 • 10:00 AM

Pentecostalism in West Africa: A Boon or Barrier to Disease?

How has Ghana stayed Ebola-free despite being at high risk for infection? A look at their American-style Pentecostalism, a religion that threatens to do more harm than good.


December 19 • 8:00 AM

Don’t Text and Drive—Especially If You’re Old

A new study shows that texting while driving becomes even more dangerous with age.


December 19 • 6:12 AM

All That ‘Call of Duty’ With Your Friends Has Not Made You a More Violent Person

But all that solo Call of Duty has.


December 19 • 4:00 AM

Food for Thought: WIC Works

New research finds participation in the federal WIC program, which subsidizes healthy foods for young children, is linked with stronger cognitive development and higher test scores.


December 18 • 4:00 PM

How I Navigated Life as a Newly Sober Mom

Saying “no” to my kids was harder than saying “no” to alcohol. But for their sake and mine, I had to learn to put myself first sometimes.


December 18 • 2:00 PM

Women in Apocalyptic Fiction Shaving Their Armpits

Because our interest in realism apparently only goes so far.


December 18 • 12:00 PM

The Paradox of Choice, 10 Years Later

Paul Hiebert talks to psychologist Barry Schwartz about how modern trends—social media, FOMO, customer review sites—fit in with arguments he made a decade ago in his highly influential book, The Paradox of Choice: Why More Is Less.


December 18 • 10:00 AM

What It’s Like to Spend a Few Hours in the Church of Scientology

Wrestling with thetans, attempting to unlock a memory bank, and a personality test seemingly aimed at people with depression. This is Scientology’s “dissemination drill” for potential new members.


December 18 • 8:00 AM

Gendering #BlackLivesMatter: A Feminist Perspective

Black men are stereotyped as violent, while black women are rendered invisible. Here’s why the gendering of black lives matters.


December 18 • 7:06 AM

Apparently You Can Bring Your Religion to Work

New research says offices that encourage talk of religion actually make for happier workplaces.


December 18 • 6:00 AM

The Very Weak and Complicated Links Between Mental Illness and Gun Violence

Vanderbilt University’s Jonathan Metzl and Kenneth MacLeish address our anxieties and correct our assumptions.


December 18 • 4:00 AM

Should Movies Be Rated RD for Reckless Driving?

A new study finds a link between watching films featuring reckless driving and engaging in similar behavior years later.


December 17 • 4:00 PM

How to Run a Drug Dealing Network in Prison

People tend not to hear about the prison drug dealing operations that succeed. Substance.com asks a veteran of the game to explain his system.


December 17 • 2:00 PM

Gender Segregation of Toys Is on the Rise

Charting the use of “toys for boys” and “toys for girls” in American English.


December 17 • 12:41 PM

Why the College Football Playoff Is Terrible But Better Than Before

The sample size is still embarrassingly small, but at least there’s less room for the availability cascade.


December 17 • 11:06 AM

Canadian Kids Have a Serious Smoking Problem

Bootleg cigarette sales could be leading Canadian teens to more serious drugs, a recent study finds.


December 17 • 10:37 AM

A Public Lynching in Sproul Plaza

When photographs of lynching victims showed up on a hallowed site of democracy in action, a provocation was issued—but to whom, by whom, and why?


December 17 • 8:00 AM

What Was the Job?

This was the year the job broke, the year we accepted a re-interpretation of its fundamental bargain and bought in to the push to get us to all work for ourselves rather than each other.


December 17 • 6:00 AM

White Kids Will Be Kids

Even the “good” kids—bound for college, upwardly mobile—sometimes break the law. The difference? They don’t have much to fear. A professor of race and social movements reflects on her teenage years and faces some uncomfortable realities.



December 16 • 4:00 PM

How Fear of Occupy Wall Street Undermined the Red Cross’ Sandy Relief Effort

Red Cross responders say there was a ban on working with the widely praised Occupy Sandy relief group because it was seen as politically unpalatable.


Follow us


Don’t Text and Drive—Especially If You’re Old

A new study shows that texting while driving becomes even more dangerous with age.

Apparently You Can Bring Your Religion to Work

New research says offices that encourage talk of religion actually make for happier workplaces.

Canadian Kids Have a Serious Smoking Problem

Bootleg cigarette sales could be leading Canadian teens to more serious drugs, a recent study finds.

The Hidden Psychology of the Home Ref

That old myth of home field bias isn’t a myth at all; it’s a statistical fact.

The Big One

One in two United States senators and two in five House members who left office between 1998 and 2004 became lobbyists. November/December 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.